TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia.
about
Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescentsRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsHematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.Treosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease.CMV-specific immune reconstitution following allogeneic stem cell transplantation.Preservation of Antigen-Specific Functions of αβ T Cells and B Cells Removed from Hematopoietic Stem Cell Transplants Suggests Their Use As an Alternative Cell Source for Advanced Manipulation and Adoptive Immunotherapy.Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimen.Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection versus CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation.Low-dose donor memory T-cell infusion after TCR alpha/beta depleted unrelated and haploidentical transplantation: results of a pilot trial.NK Cells and γδT Cells for Relapse Protection After Allogeneic Hematopoietic Cell Transplantation (HCT).Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease.Haploidentical HCT using an αβ T-cell-depleted graft with targeted αβ(+) cells by add-back after a reduced intensity preparative regimen containing low-dose TBI.T-Cell Manipulation Strategies to Prevent Graft-Versus-Host Disease in Haploidentical Stem Cell Transplantation.High-Risk Leukemia: Past, Present, and Future Role of NK Cells.
P2860
Q26750995-56A6AED6-182F-405C-ADFB-8CF6D6D68751Q28079823-DFFDB28E-C840-4DA4-8FDC-F349E71B9C56Q38690071-9A903EEC-F273-4AE4-A940-040F17758872Q38908093-DB2FB70C-6A95-4254-A836-7BAA91362E80Q38942459-532B8AAA-AD10-4D1B-BF07-181E96C02E71Q40253951-25B1BEDF-0156-4F65-85C2-1540A16012B7Q47681511-75DA97D2-A5A7-46D5-A5A6-34D4E65606F2Q47805418-B789014F-13B0-441B-A739-C0C9701D467BQ48362228-BA1C5FED-0E02-48CB-A149-B9E36ED0F193Q49333274-687D2372-22AB-471C-9188-58BA2DE0A036Q52763837-1F31883F-76D6-47B0-B9C7-258F2F0BB568Q53105512-00E0A255-7657-4A2E-947A-F9B30E0CA627Q55060181-CCDC522B-A49E-4B32-AE4A-354C8B139A70Q55172823-C712B96D-E6FB-466F-97C1-1060E2297A28
P2860
TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
TCR-alpha/beta and CD19 deplet ...... n with acute myeloid leukemia.
@en
type
label
TCR-alpha/beta and CD19 deplet ...... n with acute myeloid leukemia.
@en
prefLabel
TCR-alpha/beta and CD19 deplet ...... n with acute myeloid leukemia.
@en
P2093
P2860
P356
P1476
TCR-alpha/beta and CD19 deplet ...... en with acute myeloid leukemia
@en
P2093
A Kazachenok
D Baidildina
E Boyakova
E Kurnikova
G Novichkova
L Shelikhova
M Persiantseva
P2860
P2888
P304
P356
10.1038/BMT.2015.343
P407
P577
2016-01-25T00:00:00Z
P5875
P6179
1049171973